Clinical course, social functioning, quality of life and medication toler-ability during three years of treatment: Final results from the schizophrenia outpatient health outcomes (SOHO)study

被引：0

作者：

Jones, PB

Novick, D

Brown, J

Suarez, D

Kennedy, L

Haro, JM

机构：

[1] Univ Cambridge, Dept Psychiat, Cambridge CB2 1TN, England

[2] Eli Lilly & Co, Windlesham GU20 6PH, Surrey, England

[3] San Joan Deu SSM, Res & Dev Unit, Barcelona, Spain

来源：

SCHIZOPHRENIA RESEARCH | 2006年 / 81卷

关键词：

D O I：

暂无

中图分类号：

R749 [精神病学];

学科分类号：

100205 ;

摘要：

引用

页码：60 / 60

页数：1

共 50 条

[21] Extrapyramidal symptoms after six months of treatment: Results from the schizophrenia outpatient health outcomes (SOHO) study
Wright, R
Haro, JM
Frewer, P
Novick, D
Edgell, ET
EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2003, 13 : S341 - S342
[22] Tolerability of outpatient antipsychotic treatment: 6-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
Lambert, K
Jones, P
Novick, D
Lorenzo, M
Tzivelekis, S
Ratcliffe, M
SCHIZOPHRENIA RESEARCH, 2004, 67 (01) : 188 - 188
[23] Pharmacological treatment and other predictors of treatment outcomes in previously untreated patients with schizophrenia: results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study
Gasquet, I
Haro, JM
Novick, D
Edgell, ET
Kennedy, L
Lepine, JP
INTERNATIONAL CLINICAL PSYCHOPHARMACOLOGY, 2005, 20 (04) : 199 - 205
[24] Use of concomitant medication with antipsychotic treatment in outpatients with schizophrenia: Results from the European Schizophrenia Outpatients Health Outcomes (SOHO) study
Novick, D
Bousono, M
Suarez, D
Olivares, JM
Montejo, AL
Haro, JM
Edgell, ET
Ratcliffe, M
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2005, 29 (06) : 970 - 980
[25] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the Pan-European SOHO (schizophrenia outpatient health outcomes) study
Novick, D
BIOLOGICAL PSYCHIATRY, 2005, 57 (08) : 71S - 71S
[26] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia: 24-month results from the pan-European SOHO (schizophrenia outpatient health outcomes) study
Haro, J
Novick, D
Belger, M
Tzivelekis, S
Murray, D
Texeira, JM
Alonso, J
Bousono, MG
Gasquet, I
Kristensen, H
Jones, PB
Croudace, T
Knapp, M
Lepine, JP
Mavreas, V
Naber, D
Pancheri, P
Slooff, CJ
SCHIZOPHRENIA BULLETIN, 2005, 31 (02) : 486 - 486
[27] Change in clinical status, social functioning, weight and sexual adverse events over the first 6 months of treatment: pan-european results from the schizophrenia outpatient health outcomes (SOHO) study
V Mavreas
D Novick
S Tzivelekis
M Ratcliffe
Annals of General Hospital Psychiatry, 2 (Suppl 1):
[28] Predictors of antipsychotic treatment continuation in the outpatient setting: 12-month results from the Schizophrenia Outpatient Health Outcomes (SOHO) study
Haro, JM
Novick, D
Belger, M
Tzivelekis, S
Ratcliffe, M
INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2004, 7 : S233 - S234
[29] Antipsychotic treatment discontinuation in the outpatient treatment for schizophrenia. 24-month results from the Pan-European SOHO (Schizophrenia Outpatient Health Outcomes) study
Haro, JM
Novick, D
Belger, M
Tzivelekis, S
Bushe, C
Murray, D
Texeira, JM
JOURNAL OF PSYCHOPHARMACOLOGY, 2005, 19 (05) : A10 - A10
[30] ADHERENCE WITH ANTIPSYCHOTIC TREATMENT MEDICATION IN OUTPATIENTS WITH SCHIZOPHRENIA: 36-MONTH RESULTS FROM THE SCHIZOPHRENIA OUTPATIENTS HEALTH OUTCOMES (SOHO) STUDY
Novick, D.
Suarez, D.
Haro, J. M.
Haddad, P. M.
EUROPEAN PSYCHIATRY, 2009, 24

← 1 2 3 4 5 →